September 14-15, 2017: World Anti-Microbial Resistance Congress, Washington D.C., USA

September 14-15, 2017: World Anti-Microbial Resistance Congress, Washington D.C., USA
June 28, 2017 Sabine Bamert
In Conferences & events

September 14, 2017 – 15:10-15:50: Pathogen specific trial design to target multidrug resistant bacteria (MDR )

Dr. Glenn E. Dale, Head of Early Development, Antimicrobials, will speak in the panel discussion about the big challenge – pathogen specific trial design to target multidrug resistant bacteria (MDR ).

  • Screening hundreds of patients to enroll 1. How to overcome this while keeping trials ethical and producing robust statistical data?
  • Getting patients to MDR clinical trial centers when they have life threatening infections
  • Identifying the best comparator drug
  • Using Bayesian statistical analysis and exploring the creation of clinical trial networks

http://www.terrapinn.com/conference/antimicrobial-resistance-congress-usa/